Abstract
Ovarian steroid hormones, estrogen and progestin, affect the function of the serotonin neural system by inhibiting serotonin re-uptake through allosteric interaction with the serotonin transporter (SERT) in a nongenomic mechanism. Blocking or reducing serotonin re-uptake at the synapse alleviates depression. The aim of this study was to test the effect of compounds of the isoflavan and isoflavene groups, subclasses of the flavonoids family, on serotonin re-uptake and to compare the results with the effect of other known phytoestrogens like genistein and daidzein to relate the activity of these compounds to their structure. The effect of these compounds on the re-uptake of radioactive serotonin was assayed in HEK-293 cells stably expressed the recombinant human serotonin transporter (hSERT). The results demonstrated that the isoflavans glabridin and 4′-O-methylglabridin (4′-OMeG) and the isoflavene glabrene inhibited serotonin re-uptake by 60, 53 and 47%, respectively, at 50 µM, whereas resorcinol, the isoflavan 2′-O-methylglabridin (2′-OMeG), and the isoflavones genistein and daidzein were inactive. The inhibition of serotonin re-uptake is dose dependant with glabridin and estradiol. These results emphasize the importance of the lipophilic part of the isoflavans, as well as the hydroxyl at position 2′ on ring B. In conclusion, this study showed that several isoflavans are unique phytoestrogens, which like estradiol, affects the serotonergic system and inhibits serotonin re-uptake and, thus, potentially may be beneficial for mild to moderate depression in pre- and postmenopausal women.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Anstead G. M., Carlson K. E., and Katzenellenbogen J. A. (1997) The estradiol pharmacophore: ligand structure-estrogen receptor binding affinity relationships and a model for the receptor binding site. Steroids 62(3), 268–303.
Archer J. S. (1999) NAMS/Solvay Resident Essay Award. Relationship between estrogen, serotonin, and depression. Menopause 6(1), 71–78.
Barker E. L. and Blakely R. D. (1995) Norepinephrine and serotonin transporter: molecular targets of antide-pressant drugs, in Psychopharmacology: The Fourth Generation of Progress, Bloom F. E. and Kupfer D. J., eds., Raven, New York, pp. 321–333.
Belinky P. A., Aviram M., Mahmood S., and Vaya J. (1998) Structural aspects of the inhibitory effect of glabridin on LDL oxidation. Free Radic. Biol. Med. 24(9), 1419–1429.
Bethea C. L., Pecins-Thompson M., Schutzer W. E., Gundlah C., and Lu Z. N. (1998) Ovarian steroids and serotonin neural function. Mol. Neurobiol. 18(2), 87–123.
Chang A. S. and Chang S. M. (1999) Nongenomic steroidal modulation of high-affinity serotonin transport. Biochim. Biophys. Acta 1417(1), 157–166.
Egner U., Heinrich N., Ruff M., Gangloff M., Mueller-Fahrnow A., and Wurtz J. M. (2001) Different ligands-different receptor conformations: modeling of the hER alpha LBD in complex with agonists and antagonists. Med. Res. Rev. 21(6), 523–539.
Eshleman A. J., Carmolli M., Cumbay M., Martens C. R., Neve K. A., and Janowsky A. (1999) Characteristics of drug interactions with recombinant biogenic amine transporters expressed in the same cell type. J. Pharmacol. Exp. Ther. 289(2), 877–885.
Fozzard J. (1989) Peripheral actions of 5-hydroxytryptamine, in Peripheral Actions of 5-Hydroxytryptamine, Fozzard J., ed., Oxford University Press, New York, p. 410.
Fuller R. W. (1994) Uptake inhibitors increase extracellular serotonin concentration measured by brain microdialysis. Life Sci. 55(3), 163–167.
Mackey R. and Eden J. (1998) Phytoestrogens and the menopause. Climacteric 1(4), 302–308.
Qian Y., Galli A., Ramamoorthy S., Risso S., DeFelice L. J., and Blakely R. D. (1997) Protein kinase C activation regulates human serotonin transporters in HEK-293 cells via altered cell surface expression. J. Neurosci. 17(1), 45–57.
Rubinow D. R., Schmidt P. J., and Roca C. A. (1998) Estrogen-serotonin interactions: implications for affective regulation. Biol. Psychiatry 44(9), 839–850.
Tamir S., Eizenberg M., Somjen D., Stern N., Shelach R., Kaye A., and Vaya J. (2000) Estrogenic and antiproliferative properties of glabridin from licorice in human breast cancer cells. Cancer Res. 60(20), 5704–5709.
Tamir S., Eizenberg M., Somjen D., Izrael S., and Vaya J. (2001) Estrogen-like activity of glabrene and other constituents isolated from licorice root. J. Steroid Biochem. Mol. Biol. 78(3), 291–298.
Tamir S., Izrael S., and Vaya J. (2002) The effect of oxidative stress on ERa and ERb expression. J. Steroid Biochem. Mol. Biol. 81, 327–332.
Vaya J., Belinky P. A., and Aviram M. (1997) Antioxidant constituents from licorice roots: isolation, structure elucidation and antioxidative capacity toward LDL oxidation. Free Radic. Biol. Med. 23(2), 302–313.
Wiseman H. (2000) The therapeutic potential of phytoestrogens. Expert Opin. Invest. Drugs 9(8), 1829–1840.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ofir, R., Tamir, S., Khatib, S. et al. Inhibition of serotonin re-uptake by licorice constituents. J Mol Neurosci 20, 135–140 (2003). https://doi.org/10.1385/JMN:20:2:135
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1385/JMN:20:2:135